Obesity’s connection to severe health issues like diabetes, hypertension, stroke, and cancer underscores the public health challenges of this crisis—a critical step toward achieving a healthier world.
The global issue of obesity is escalating, impacting nearly 1 billion people classified as obese according to BMI standards in 2020, all while striving for a healthier world.
According to an article published by Freethink, in the pursuit of a healthier world, the global issue of obesity is rapidly escalating, affecting nearly 1 billion people according to BMI standards in 2020. If current trends persist, this number could soar to 1.9 billion by 2035, impacting approximately 24% of the world’s population.
Additionally, an extra 27% will be categorized as overweight. Notably, certain regions, including the US, already grapple with disproportionately high rates of obesity.
This pressing crisis presents substantial challenges to public health, as obesity is intricately linked to grave health complications such as diabetes, hypertension, stroke, and cancer. The year 2019 alone witnessed obesity contributing to 5 million deaths, comprising 8.5% of the total mortality count, and this figure continues to climb.
Beyond the realm of physical health risks, obesity carries a stigma that can precipitate mental health issues such as depression and diminished self-esteem. Regrettably, obtaining adequate medical care for these challenges frequently proves challenging due to the discrimination confronted by individuals grappling with excess weight.
In our journey towards fostering a healthier world, addressing these multifaceted concerns surrounding obesity becomes imperative.
In a healthier world, the conventional advice for addressing obesity has been to reduce calorie intake and increase physical activity, but achieving this is challenging due to a variety of physical, mental, and social factors.
The perception of obesity is gradually shifting from being viewed as a moral failing to being recognized as a medical condition, sparking the development of new treatments that can contribute to a healthier world and help individuals achieve sustainable weight loss.
A significant leap forward in the realm of obesity treatment is the emergence of GLP-1 agonist drugs. Initially formulated to manage diabetes, these drugs have demonstrated an additional effect of triggering weight loss and promoting a healthier world by simulating the actions of the GLP-1 hormone, which effectively reduces feelings of hunger.
By advancing our understanding and approach to obesity treatment, we can pave the way for a healthier world and the well-being of individuals struggling with weight issues, offering them improved chances of achieving sustainable weight loss.
Extensive clinical trials have revealed that participants undergoing treatment with these medications can shed anywhere between 10-20% of their body weight, and remarkably, this weight loss can be maintained over the course of the treatment, contributing to a healthier world.
Noteworthy players in the category of GLP-1 agonists include Novo Nordisk’s Wegovy (semaglutide) and Saxenda (liraglutide), both of which have secured FDA approval for obesity treatment. Meanwhile, promising candidates like Eli Lilly’s Mounjaro (tirzepatide) are undergoing evaluation in clinical trials.
READ ALSO: US Accused China and Russia of Blocking Unified UN Response to North Korea’s Missile Launches
However, accessibility remains a concern due to the high cost associated with these drugs. Encouragingly, trials have indicated that semaglutide might not only assist in weight loss but also lower the risks of heart disease, potentially influencing insurance coverage policies.
According to an article published by Healio, the landscape of innovative treatments extends beyond medication, encompassing brain stimulation as a potential avenue. Researchers are delving into stimulating the “nucleus accumbens” to aid weight loss, particularly in individuals struggling with binge eating disorders.
Furthermore, brain regions that regulate hunger are also under scrutiny as potential sites for targeted stimulation.
The horizon of obesity treatment is broadening further to encompass gene therapies. In a striking example, scientists successfully edited a gene in stem cells extracted from adipose tissue, resulting in weight loss in mice subjects.
While these approaches are still in their nascent stages, they hold the promise of providing long-term alternatives to traditional drug-based treatments.
Exploration into numerous innovative obesity treatments continues, spanning exercise-mimicking drugs, light-based methods to induce satiety, and even novel applications of psychedelic drugs.
In order to truly address this complex global health challenge in a healthier world, it’s imperative to ensure that these treatments remain accessible to all individuals. Additionally, tackling the deeply ingrained stigma surrounding obesity is crucial, as it plays a pivotal role in shaping perceptions and treatment approaches.